The pharmacokinetics and pharmacodynamics of follicle-stimulating hormone after multiple subcutaneous doses of highly purified urofollitrophin (hp-FSH; Fostimon- IBSA) in healthy fertile women

Trial Profile

The pharmacokinetics and pharmacodynamics of follicle-stimulating hormone after multiple subcutaneous doses of highly purified urofollitrophin (hp-FSH; Fostimon- IBSA) in healthy fertile women

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Urofollitropin (Primary)
  • Indications Female infertility
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors IBSA
  • Most Recent Events

    • 04 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top